Pasadena, CA, United States of America

Joseph McNulty

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 12(Granted Patents)


Location History:

  • Los Angeles, CA (US) (2018)
  • Pasadena, CA (US) (2018 - 2022)

Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Joseph McNulty

Introduction

Joseph McNulty is a notable inventor based in Pasadena, California. He has made significant contributions to the field of biotechnology, particularly in the development of gene therapeutic systems. With a total of six patents to his name, McNulty's work has had a profound impact on diagnostic and therapeutic applications.

Latest Patents

Among his latest patents, McNulty has developed nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases. These innovations include their use in both diagnostic and therapeutic applications. The thymidine kinases can be mutated using conservative mutations, non-conservative mutations, or both. Additionally, he has provided gene therapeutic systems that include viral and retroviral particles. Another significant patent is the thymidine kinase diagnostic assay for gene therapy applications, which also focuses on improved Herpes Simplex Virus Thymidine Kinases.

Career Highlights

Throughout his career, Joseph McNulty has worked with various companies that have allowed him to advance his research. Notably, he has been associated with Genvivo, Inc. and Epeius Biotechnologies Corporation. His work in these organizations has contributed to the development of innovative solutions in the biotechnology sector.

Collaborations

Collaboration has been a key aspect of McNulty's career. He has worked alongside esteemed colleagues such as John P. Levy and Rebecca

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…